Profile
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Company Name Adial Pharmaceuticals, Inc. WT EXP 073123 Vanguard Total Stock Mkt Idx Instl Pls Vanguard 500 Index Fd Admiral Shs Vanguard Total International Stock Index Fd Admiral Merrill Lynch Capital Trust I GTD CAP 6.45% American Funds American Balanced 529A
Sector - - - - - -
Industry - - - - - -
Market Cap - $2,139.08B $1,179.31B $429.04B $327.64B $226.66B
Employees 0.00K 0.00K 0.00K 0.00K 0.00K 0.00K
CEO - - - - - -
Ratings
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Quant Rating Score 2 4
Quant Rating Sell Buy
Trading
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Last Close $0.0009 $254.84 $523.1 $33.65 $25.45 $35.45
High 52 $0.01 $252.6 $519.96 $33.75 $25.89 $35.27
Low 52 - $214.31 $380.14 $27.44 $24.61 $33.05
Price vs. 52 Week High -91 % 0.89 % 0.6 % -0.3 % -1.7 % 0.51 %
Price vs. 52 Week Low 0 % 18.91 % 37.61 % 22.63 % 3.41 % 7.26 %
Total Return
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
1 Month Return 0 % 4.67 % 4.06 % 3.7 % 0.67 % 2.84 %
3 Month Return 0 % 11.98 % 12.17 % 8.16 % 0.83 % 0 %
6 Month Return 0 % 18.22 % 18.93 % 10.98 % 0.3 % 0 %
9 Month Return 0 % 0 % 29.56 % 17.37 % 2.41 % 0 %
YTD Return 0 % 0 % 18.89 % 8.27 % 0.59 % 0 %
1 Year Return -85 % 0 % 25.78 % 9.04 % 1.11 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Dividend Yield Percentage (TTM) - 0.65 % 0.93 % 2.17 % 2.17 % 2.16 %
Dividend Paid and Capex Coverage Ration (TTM) - - - - -10.65 % -
Dividend Per Share (TTM) - 1.64 % 4.84 % 0.73 % 0.96 % 0.76 %
Payout Ratio (TTM) - - - - 8.38 % -
Growth
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Asset Growth -17.37 % 4.24 %
Gross Profit Growth 99.07 % 1.93 %
Revenue Growth - 3.82 %
Revenue 3 Year - 44.83 %
Revenue 5 Year - 41.3 %
Revenue 10 Year - 56.96 %
EBIT Growth 48.28 % -8.48 %
Net Income Growth 39.14 % -3.68 %
Net Income 3 Yeari Growth Per Share 75.04 % 61.55 %
Net Income 5 Yeari Growth Per Share 91.1 % 18.47 %
Net Income 10 Yeari Growth Per Share -27.17 % 210.04 %
Operating Income Growth 48.28 % -8.48 %
Operating Cash Flow Growth (CFG) 39.15 % 810.95 %
Operating 3 Year CFG 68.8 % 29.08 %
Operating 5 Year CFG 63.59 % 43.14 %
Operating 10 Year CFG -96.44 % -35.22 %
EPS Growth 98.29 % -3.43 %
EPS Diluted Growth 98.29 % -3.45 %
Book Value Per Share -96.5 % 7.88 %
Share Holder 3 Year Equity Growth Per Share -64.15 % 16.5 %
Share Holder 5 Year Equity Growth Per Share -87.71 % 38.23 %
Share Holder 10 Year Equity Growth Per Share 236.06 % 67.53 %
Dividend Per Share Growth - 7.08 %
Dividend 3 Year Growth Per Share - 28.21 %
Dividend 5 Year Growth Per Share - 65.74 %
Dividend 10 Year Growth Per Share - 624.26 %
Debt Growth -100 % 10.36 %
Free Cash Flow Growth 39.15 % 810.95 %
Updated On 31 Dec 2023 31 Dec 2023
Profitability
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Gross Profit Margin TTM - -12 %
Return on Assets TTM -324.3 % 0.92 %
Return on Equity TTM -279.83 % 10.4 %
Return on Capital Employed TTM -626.44 % 0.48 %
Net Income Per EBT TTM 99.4 % 92.5 %
EBT Per Ebit TTM 96.59 % 208.17 %
EBIT Per Revenue TTM - 34.35 %
Cash Flow To Debt Ratio TTM -5669.9 % -7.81 %
Receivables Turnover TTM - -
Payables Turnover TTM - -
Inventory Turnover TTM - -
Fixed Asset Turnover TTM - 381.67 %
Asset Turnover TTM - 1.39 %
Operating Cash Flow Per Share TTM -0.42 -3.37
Free Cash Flow Per Share TTM -0.42 -3.37
Cash Per Share TTM 8.74 % 394.18 %
Operating Cash Flow Sales Ratio TTM - -59.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 100 %
Cash Flow Coverage Ratios TTM -5669.9 % -7.81 %
Price To Free Cash Flows Ratio TTM -0.43 -12.87
Price To Operating Cash Flows Ratio TTM -2.7 -13.11
Price Cash Flow Ratio TTM -2.7 -13.11
Income Statement (TTM)
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Revenue $0B $98.58B
Gross Profit $-0B $94.19B
Gross Profit Ratio 0% 95.54%
EBITDA $-0.01B $30.37B
Net Income $-0.01B $26.52B
EPS Diluted -5.44 3.08
Balance Sheet (MRQ)
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Long Term Debt $0B $302.2B
Total Liabilities $0B $2888.51B
Total Equity $0B $291.65B
Total Investments $0B $358.85B
Total Debt $0B $334.3B
Total Assets $0B $3180.15B
Cash Flow Statement (TTM)
ADILW VSMPX VFIAX VTIAX MER-PK CLBAX
Net Income $-0.01B $26.52B
Inventory $0B $0B
Dividends Paid $0B $-9.09B
Operating Cash Flow $-0.01B $44.98B
Capital Expenditure $0B $0B
Related Stocks
Ticker Name Price
AAACX Alpha Alternative Assets Fund 6.2
AAC-WT Ares Acquisition Corporation Re 0.63
AACQU Artius Acquisition Inc. 11.05
AADEX American Beacon Large Cap Value R5 29.05
AAIDX Axonic Alternative Income Fund 20.24
AAIN Arlington Asset Investment Corp 23.5
AAQC-WT 0.0057
AARTX Stone Ridge Trust VIII 10.92
ABRTX ABR DYNAMIC BLEND EQUITY & VOLATILITY FUND - INVESTOR SHARES 11.25
ACCNX American Century Core Plus Fd Investor Cl 9.23
ACHR-WT 0.7629
ACRO-WT 0.0105
ADEX-WT Adit EdTech Acquisition Corp. R 0.084
ADRA-UN Adara Acquisition Corp. 8.7
ADRA-WT Adara Acquisition Corp. 0.0488
AEMGX Acadian Emerging Markets Portfolio Investor Class 23.8
AEVA-WT Aeva Technologies, Inc. Redeema 0.03499
AFDVX Applied Finance Explorer fund Investor Class 22.57
AFJKR Aimei Health Technology Co., Ltd Right 0.21
AFTR-WT 0.0041
Unlock